Viral transduction of the HER2-extracellular domain expands trastuzumab-based photoimmunotherapy for HER2-negative breast cancer cells-Reference-Cited by-同舟云学术

Viral transduction of the HER2-extracellular domain expands trastuzumab-based photoimmunotherapy for HER2-negative breast cancer cells

Published:2015-01-24 Issue:3 Volume:149 Page:597-605
ISSN:0167-6806
Container-title:Breast Cancer Research and Treatment
language:en
Short-container-title:Breast Cancer Res Treat

Author:

Shimoyama Kyoko,Kagawa Shunsuke,Ishida Michihiro,Watanabe Shinichiro,Noma Kazuhiro,Takehara Kiyoto,Tazawa Hiroshi,Hashimoto Yuuri,Tanabe Shunsuke,Matsuoka Junji,Kobayashi Hisataka,Fujiwara Toshiyoshi

Funder

the Ministry of Education Culture, Sports, Science and Technology, Japan

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology

Link

http://link.springer.com/content/pdf/10.1007/s10549-015-3265-y.pdf

Reference36 articles.

1. Slamon DJ, Godolphin W, Jones LA, Holt JA, Wong SG, Keith DE, Levin WJ, Stuart SG, Udove J, Ullrich A et al (1989) Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancer. Science (New York, N.Y.) 244:707–712

2. Dawood S, Broglio K, Buzdar AU, Hortobagyi GN, Giordano SH (2010) Prognosis of women with metastatic breast cancer by HER2 status and trastuzumab treatment: an institutional-based review. J Clin Oncol 28:92–98. doi: 10.1200/jco.2008.19.9844

3. Slamon DJ, Clark GM, Wong SG, Levin WJ, Ullrich A, McGuire WL (1987) Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene. Science 235:177–182

4. Carlsson J, Nordgren H, Sjostrom J, Wester K, Villman K, Bengtsson NO, Ostenstad B, Lundqvist H, Blomqvist C (2004) HER2 expression in breast cancer primary tumours and corresponding metastases. Original data and literature review. Br J Cancer 90:2344–2348. doi: 10.1038/sj.bjc.6601881

5. Nahta R, Yu D, Hung MC, Hortobagyi GN, Esteva FJ (2006) Mechanisms of disease: understanding resistance to HER2-targeted therapy in human breast cancer. Nat Clin Pract Oncol 3:269–280. doi: 10.1038/ncponc0509

Cited by 24 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Development of a red-shifted photosensitizer for near-infrared photoimmunotherapy of cancer;Journal of Photochemistry and Photobiology;2024-04

2. Near Infrared Photoimmunotherapy: A Review of Recent Progress and Their Target Molecules for Cancer Therapy;International Journal of Molecular Sciences;2023-01-31

3. Antibody Drug Conjugates of Near-Infrared Photoimmunotherapy (NIR-PIT) in Breast Cancers;Technology in Cancer Research & Treatment;2023-01

4. Photoimmunotherapy for Cancer Treatment;Handbook of Cancer and Immunology;2023

5. Dual-targeted near-infrared photoimmunotherapy for esophageal cancer and cancer-associated fibroblasts in the tumor microenvironment;Scientific Reports;2022-11-23